These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6281105)

  • 1. Herpes simplex vaccine using cell membrane associated antigen in an animal model.
    Thornton B; Griffiths JB; Walkland A
    Dev Biol Stand; 1981; 50():201-6. PubMed ID: 6281105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
    Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus subunit vaccine: characterization of the virus strain used and testing of the vaccine.
    Hilfenhaus J; Moser H; Herrmann A; Mauler R
    Dev Biol Stand; 1982; 52():321-31. PubMed ID: 6299841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR; Heath AW; Jennings R
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface antigen produced by herpes simplex virus (HSV).
    Ito M; Barron AL
    J Immunol; 1972 Mar; 108(3):711-8. PubMed ID: 4334880
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents.
    Ertürk M; Welch MJ; Phillpotts RJ; Jennings R
    Vaccine; 1989 Oct; 7(5):431-6. PubMed ID: 2554607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Pack CD; Kumaraguru U; Suvas S; Rouse BT
    Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on treatment of HSV infections with photodynamic therapy using 5-aminolevulinic acid].
    Tao JN; Duan SM; Li J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):79-82. PubMed ID: 17429545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple novel procedure for preparation of herpes simplex virus subunit vaccine.
    Rajcáni J; Matis J; Kúdelová M; Lesko J; Reichel M; Fuchsberger N; Lesso J
    Acta Virol; 1988 Jul; 32(4):317-28. PubMed ID: 2903636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure of antibody dependent cellular cytotoxicity in HSV 1 infected and uninfected Chang liver cells.
    Kournikakis B; Bozzola JJ; Murasko DM
    Cytobios; 1986; 47(189):73-84. PubMed ID: 3022993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of antiviral serum on cells infected with herpes simplex virus type 1.
    Karmysheva VY; Rajcáni J
    Acta Virol; 1982 Jan; 26(1-2):79-85. PubMed ID: 6124113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.